Compounds > ezogabine
Page last updated: 2024-09-03

ezogabine and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

ezogabine has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies

Compound Research Comparison

Studies
(ezogabine)		Trials
(ezogabine)		Recent Studies (post-2010)
(ezogabine)		Studies
(15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)		Trials
(15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)		Recent Studies (post-2010) (15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid)
383262412,57727327

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrese, V; Currò, D; Ipavec, V; Martire, M; Taglialatela, M1

Other Studies

1 other study(ies) available for ezogabine and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

ArticleYear
KV7 channels regulate muscle tone and nonadrenergic noncholinergic relaxation of the rat gastric fundus.
    Pharmacological research, 2011, Volume: 64, Issue:4

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Anticonvulsants; Carbamates; Female; Gastric Fundus; KCNQ Potassium Channels; Male; Muscle Relaxation; Muscle Tonus; Phenylenediamines; Rats; Rats, Wistar

2011